 Akira Miyake
Concepts (759)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Individuality | 19 | 2023 | 146 | 3.490 |
Why?
| | Executive Function | 13 | 2019 | 379 | 2.350 |
Why?
| | Memory, Short-Term | 11 | 2021 | 225 | 1.940 |
Why?
| | Cognition | 16 | 2023 | 988 | 1.730 |
Why?
| | Attention | 14 | 2023 | 393 | 1.550 |
Why?
| | Reading | 7 | 2017 | 149 | 1.340 |
Why?
| | Aptitude | 6 | 2017 | 38 | 1.210 |
Why?
| | Self-Control | 3 | 2023 | 48 | 1.130 |
Why?
| | Ego | 3 | 2023 | 11 | 0.930 |
Why?
| | Self Concept | 2 | 2016 | 213 | 0.780 |
Why?
| | Memory | 6 | 2016 | 211 | 0.710 |
Why?
| | Universities | 2 | 2021 | 339 | 0.710 |
Why?
| | Psychomotor Performance | 6 | 2018 | 280 | 0.700 |
Why?
| | Reaction Time | 9 | 2018 | 376 | 0.700 |
Why?
| | Anxiety | 2 | 2016 | 840 | 0.670 |
Why?
| | Pessimism | 1 | 2019 | 4 | 0.650 |
Why?
| | Internal-External Control | 2 | 2016 | 66 | 0.630 |
Why?
| | Task Performance and Analysis | 2 | 2016 | 159 | 0.620 |
Why?
| | Comprehension | 2 | 2017 | 155 | 0.600 |
Why?
| | Psycholinguistics | 2 | 2017 | 18 | 0.590 |
Why?
| | Evoked Potentials | 2 | 2017 | 108 | 0.560 |
Why?
| | Students | 3 | 2022 | 501 | 0.550 |
Why?
| | Neuropsychological Tests | 14 | 2017 | 927 | 0.510 |
Why?
| | Orientation | 3 | 2002 | 39 | 0.500 |
Why?
| | Epidermal Growth Factor | 5 | 1998 | 161 | 0.500 |
Why?
| | Cerebral Cortex | 3 | 2017 | 380 | 0.470 |
Why?
| | Humans | 102 | 2023 | 114623 | 0.460 |
Why?
| | Cooperative Behavior | 1 | 2016 | 381 | 0.440 |
Why?
| | Space Perception | 4 | 2016 | 64 | 0.440 |
Why?
| | Female | 74 | 2022 | 59466 | 0.430 |
Why?
| | Learning | 2 | 2022 | 350 | 0.430 |
Why?
| | Verbal Behavior | 2 | 2004 | 43 | 0.420 |
Why?
| | Interpersonal Relations | 1 | 2016 | 341 | 0.420 |
Why?
| | Racism | 1 | 2015 | 102 | 0.420 |
Why?
| | Cognition Disorders | 4 | 2023 | 476 | 0.410 |
Why?
| | Ether-A-Go-Go Potassium Channels | 2 | 2009 | 4 | 0.390 |
Why?
| | Male | 53 | 2021 | 55554 | 0.380 |
Why?
| | Mental Recall | 6 | 2008 | 171 | 0.370 |
Why?
| | Cues | 4 | 2016 | 300 | 0.360 |
Why?
| | Physics | 1 | 2010 | 17 | 0.360 |
Why?
| | Language | 3 | 2016 | 262 | 0.360 |
Why?
| | Social Values | 1 | 2010 | 36 | 0.360 |
Why?
| | Achievement | 1 | 2010 | 54 | 0.360 |
Why?
| | Young Adult | 16 | 2019 | 10455 | 0.350 |
Why?
| | Frontal Lobe | 3 | 2008 | 141 | 0.340 |
Why?
| | Heart Defects, Congenital | 4 | 2022 | 671 | 0.340 |
Why?
| | Chromans | 3 | 1994 | 21 | 0.330 |
Why?
| | Verbal Learning | 2 | 2002 | 63 | 0.330 |
Why?
| | Brain | 4 | 2016 | 2371 | 0.330 |
Why?
| | Pattern Recognition, Visual | 3 | 2015 | 86 | 0.320 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 171 | 0.320 |
Why?
| | Phospholipases A | 3 | 1994 | 101 | 0.320 |
Why?
| | Receptors, Cholecystokinin | 4 | 1997 | 5 | 0.310 |
Why?
| | Adult | 36 | 2023 | 30528 | 0.310 |
Why?
| | Goals | 3 | 2015 | 147 | 0.300 |
Why?
| | Models, Psychological | 4 | 2016 | 296 | 0.300 |
Why?
| | Problem Solving | 3 | 2008 | 141 | 0.300 |
Why?
| | Potassium Channels | 4 | 2003 | 121 | 0.290 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 364 | 0.290 |
Why?
| | Prolactin | 7 | 2000 | 96 | 0.280 |
Why?
| | Transforming Growth Factor alpha | 3 | 1996 | 53 | 0.280 |
Why?
| | Visual Perception | 4 | 2002 | 139 | 0.280 |
Why?
| | ErbB Receptors | 5 | 1996 | 554 | 0.270 |
Why?
| | Thinking | 2 | 2021 | 53 | 0.270 |
Why?
| | Adolescent | 26 | 2019 | 17831 | 0.270 |
Why?
| | Gene-Environment Interaction | 3 | 2017 | 183 | 0.260 |
Why?
| | Music | 1 | 2006 | 39 | 0.260 |
Why?
| | Decidua | 3 | 1997 | 23 | 0.250 |
Why?
| | Receptors, Serotonin | 4 | 2000 | 32 | 0.250 |
Why?
| | Fallopian Tubes | 3 | 1999 | 29 | 0.250 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2018 | 109 | 0.250 |
Why?
| | Molecular Sequence Data | 15 | 2008 | 2785 | 0.250 |
Why?
| | Receptors, Interleukin | 2 | 1995 | 39 | 0.240 |
Why?
| | Psychological Theory | 2 | 2016 | 94 | 0.240 |
Why?
| | Growth Substances | 4 | 1998 | 138 | 0.240 |
Why?
| | Research Design | 4 | 2021 | 928 | 0.240 |
Why?
| | Pituitary Gland | 5 | 1997 | 148 | 0.240 |
Why?
| | RNA, Messenger | 15 | 2000 | 2552 | 0.230 |
Why?
| | Gene Expression | 7 | 2000 | 1421 | 0.230 |
Why?
| | Twins, Dizygotic | 4 | 2017 | 182 | 0.230 |
Why?
| | Twins, Monozygotic | 4 | 2017 | 210 | 0.220 |
Why?
| | Electroencephalography | 2 | 2017 | 362 | 0.220 |
Why?
| | Adolescent Development | 2 | 2016 | 83 | 0.220 |
Why?
| | Phenols | 2 | 1994 | 82 | 0.210 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2002 | 48 | 0.210 |
Why?
| | Long QT Syndrome | 2 | 2014 | 59 | 0.210 |
Why?
| | Nerve Tissue Proteins | 3 | 2008 | 529 | 0.210 |
Why?
| | Ovarian Neoplasms | 4 | 1999 | 388 | 0.210 |
Why?
| | Pseudohypoparathyroidism | 1 | 2001 | 3 | 0.200 |
Why?
| | Laryngismus | 1 | 2001 | 6 | 0.200 |
Why?
| | Animals | 47 | 2009 | 31694 | 0.190 |
Why?
| | Blood Alcohol Content | 1 | 2021 | 5 | 0.190 |
Why?
| | Reproducibility of Results | 4 | 2016 | 2762 | 0.190 |
Why?
| | Blotting, Northern | 8 | 1998 | 193 | 0.190 |
Why?
| | Saccades | 2 | 2015 | 35 | 0.180 |
Why?
| | Chemotactic Factors | 2 | 1997 | 50 | 0.180 |
Why?
| | Chemokines, CXC | 2 | 1997 | 60 | 0.170 |
Why?
| | Surveys and Questionnaires | 5 | 2019 | 4620 | 0.170 |
Why?
| | Polymerase Chain Reaction | 8 | 2001 | 993 | 0.170 |
Why?
| | Amino Acid Sequence | 11 | 2008 | 1982 | 0.170 |
Why?
| | Telencephalon | 1 | 1999 | 15 | 0.170 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 17 | 0.170 |
Why?
| | Cell Line | 10 | 2003 | 2635 | 0.170 |
Why?
| | Interleukin-6 | 4 | 1997 | 676 | 0.170 |
Why?
| | Mice | 19 | 2009 | 14860 | 0.160 |
Why?
| | Rats | 18 | 2000 | 4958 | 0.160 |
Why?
| | Emotions | 1 | 2023 | 472 | 0.160 |
Why?
| | Scimitar Syndrome | 1 | 2018 | 6 | 0.150 |
Why?
| | Heterotaxy Syndrome | 1 | 2018 | 10 | 0.150 |
Why?
| | Hypothalamus | 2 | 1996 | 147 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1997 | 351 | 0.150 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2018 | 29 | 0.150 |
Why?
| | Twins | 4 | 2014 | 240 | 0.150 |
Why?
| | Guidelines as Topic | 1 | 2000 | 243 | 0.150 |
Why?
| | Child Development | 2 | 2012 | 385 | 0.150 |
Why?
| | Pyridazines | 1 | 1997 | 46 | 0.140 |
Why?
| | Menstrual Cycle | 2 | 1995 | 108 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 172 | 0.140 |
Why?
| | Follicle Stimulating Hormone | 8 | 1997 | 216 | 0.140 |
Why?
| | Estradiol | 4 | 1996 | 455 | 0.140 |
Why?
| | Cystadenocarcinoma | 1 | 1996 | 2 | 0.140 |
Why?
| | CA-125 Antigen | 1 | 1996 | 12 | 0.140 |
Why?
| | Fibroblast Growth Factors | 1 | 1998 | 162 | 0.140 |
Why?
| | Arteriovenous Malformations | 1 | 1996 | 24 | 0.140 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1993 | 153 | 0.140 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1996 | 45 | 0.130 |
Why?
| | Educational Measurement | 2 | 2010 | 243 | 0.130 |
Why?
| | Motion Pictures | 1 | 2016 | 13 | 0.130 |
Why?
| | Alcoholic Intoxication | 1 | 2016 | 62 | 0.130 |
Why?
| | Mice, Inbred ICR | 5 | 1997 | 109 | 0.130 |
Why?
| | Random Allocation | 3 | 2018 | 335 | 0.130 |
Why?
| | Genetic Phenomena | 1 | 2015 | 8 | 0.130 |
Why?
| | Cloning, Molecular | 6 | 2003 | 522 | 0.130 |
Why?
| | Sample Size | 1 | 2016 | 112 | 0.130 |
Why?
| | Base Sequence | 6 | 2001 | 2114 | 0.130 |
Why?
| | Adipose Tissue | 2 | 1997 | 539 | 0.130 |
Why?
| | Japan | 5 | 2019 | 86 | 0.120 |
Why?
| | Substance-Related Disorders | 2 | 2017 | 947 | 0.120 |
Why?
| | Association | 1 | 2015 | 11 | 0.120 |
Why?
| | Dangerous Behavior | 1 | 2015 | 20 | 0.120 |
Why?
| | Vagina | 1 | 1996 | 146 | 0.120 |
Why?
| | Genotype | 2 | 2011 | 1760 | 0.120 |
Why?
| | Depression | 2 | 2015 | 1133 | 0.120 |
Why?
| | Alternative Splicing | 2 | 2000 | 187 | 0.120 |
Why?
| | Intelligence | 4 | 2011 | 130 | 0.120 |
Why?
| | Arousal | 1 | 2015 | 152 | 0.120 |
Why?
| | 3T3 Cells | 1 | 1994 | 140 | 0.120 |
Why?
| | Dextrocardia | 1 | 2014 | 3 | 0.120 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 10 | 0.120 |
Why?
| | Pregnancy, Animal | 1 | 1994 | 52 | 0.120 |
Why?
| | Phonetics | 2 | 2006 | 46 | 0.120 |
Why?
| | Stents | 1 | 2018 | 475 | 0.120 |
Why?
| | Transplantation, Heterologous | 1 | 1994 | 181 | 0.120 |
Why?
| | Neoplasm Transplantation | 1 | 1994 | 228 | 0.120 |
Why?
| | Electrocardiography | 2 | 2014 | 560 | 0.110 |
Why?
| | Exons | 1 | 1995 | 302 | 0.110 |
Why?
| | Saliva | 1 | 1995 | 187 | 0.110 |
Why?
| | Peptides | 2 | 1996 | 848 | 0.110 |
Why?
| | Genitalia, Female | 1 | 2014 | 37 | 0.110 |
Why?
| | Ethanol | 1 | 2018 | 538 | 0.110 |
Why?
| | Tumor Cells, Cultured | 9 | 2000 | 849 | 0.110 |
Why?
| | Carrageenan | 1 | 1993 | 6 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 1993 | 299 | 0.110 |
Why?
| | Macrophages, Peritoneal | 1 | 1994 | 93 | 0.110 |
Why?
| | Recombinant Proteins | 5 | 1999 | 1230 | 0.110 |
Why?
| | Anti-Asthmatic Agents | 1 | 1997 | 349 | 0.110 |
Why?
| | Motivation | 2 | 2014 | 494 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 4 | 2008 | 3039 | 0.110 |
Why?
| | Dinoprostone | 1 | 1994 | 184 | 0.110 |
Why?
| | Pituitary Gland, Anterior | 5 | 1996 | 39 | 0.110 |
Why?
| | Uterus | 4 | 1999 | 192 | 0.110 |
Why?
| | Impulsive Behavior | 1 | 2014 | 113 | 0.110 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2013 | 16 | 0.110 |
Why?
| | Adipocytes | 1 | 1994 | 188 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 8 | 2000 | 1842 | 0.110 |
Why?
| | Data Collection | 1 | 2016 | 620 | 0.110 |
Why?
| | Phenotype | 4 | 2017 | 2796 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 2013 | 51 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2002 | 353 | 0.100 |
Why?
| | Sincalide | 4 | 1997 | 5 | 0.100 |
Why?
| | Calcium | 6 | 2000 | 1104 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 91 | 0.100 |
Why?
| | Tissue Distribution | 5 | 2003 | 286 | 0.100 |
Why?
| | Immunohistochemistry | 5 | 1997 | 1629 | 0.100 |
Why?
| | Alcohol Drinking | 1 | 2018 | 651 | 0.100 |
Why?
| | Biomarkers, Tumor | 2 | 1996 | 1040 | 0.100 |
Why?
| | Equol | 1 | 2012 | 2 | 0.100 |
Why?
| | Phytoestrogens | 1 | 2012 | 13 | 0.100 |
Why?
| | Cells, Cultured | 10 | 2001 | 3881 | 0.100 |
Why?
| | Rats, Wistar | 8 | 1997 | 368 | 0.100 |
Why?
| | In Situ Hybridization | 5 | 2001 | 292 | 0.100 |
Why?
| | Longitudinal Studies | 6 | 2017 | 2387 | 0.100 |
Why?
| | Skin Aging | 1 | 2012 | 19 | 0.100 |
Why?
| | Transfection | 4 | 2003 | 866 | 0.100 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1139 | 0.100 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 186 | 0.100 |
Why?
| | Placenta | 2 | 1997 | 625 | 0.100 |
Why?
| | Binding, Competitive | 4 | 2000 | 193 | 0.100 |
Why?
| | DNA, Complementary | 5 | 2001 | 256 | 0.090 |
Why?
| | Glucose | 1 | 1996 | 896 | 0.090 |
Why?
| | Factor Analysis, Statistical | 3 | 2011 | 257 | 0.090 |
Why?
| | Pregnancy | 11 | 2022 | 5517 | 0.090 |
Why?
| | Hyponatremia | 1 | 2011 | 37 | 0.090 |
Why?
| | Reversal Learning | 1 | 2010 | 10 | 0.090 |
Why?
| | Stereotyping | 1 | 2010 | 39 | 0.090 |
Why?
| | Sodium | 1 | 2011 | 183 | 0.090 |
Why?
| | Temperament | 1 | 2010 | 46 | 0.090 |
Why?
| | Pituitary Function Tests | 1 | 1989 | 3 | 0.090 |
Why?
| | Bayes Theorem | 2 | 2022 | 329 | 0.090 |
Why?
| | Autonomic Nervous System | 1 | 2010 | 66 | 0.090 |
Why?
| | Beclin-1 | 1 | 2009 | 9 | 0.090 |
Why?
| | Postmenopause | 1 | 2012 | 303 | 0.090 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 72 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 1997 | 1016 | 0.080 |
Why?
| | Ion Channel Gating | 3 | 2002 | 83 | 0.080 |
Why?
| | Social Environment | 2 | 2009 | 283 | 0.080 |
Why?
| | Defibrillators, Implantable | 1 | 2013 | 286 | 0.080 |
Why?
| | Maze Learning | 1 | 2009 | 86 | 0.080 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 173 | 0.080 |
Why?
| | Phospholipases A2 | 3 | 1994 | 76 | 0.080 |
Why?
| | Drug Design | 1 | 2010 | 148 | 0.080 |
Why?
| | Models, Neurological | 1 | 2011 | 212 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1994 | 1141 | 0.080 |
Why?
| | Epilepsy | 1 | 2013 | 277 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 1995 | 2319 | 0.080 |
Why?
| | Atrial Fibrillation | 1 | 2013 | 322 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 1945 | 0.080 |
Why?
| | Motor Skills | 1 | 2009 | 82 | 0.080 |
Why?
| | Fontan Procedure | 1 | 2011 | 157 | 0.080 |
Why?
| | Time Factors | 9 | 2011 | 6112 | 0.080 |
Why?
| | Psoriasis | 1 | 2009 | 74 | 0.080 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 1997 | 188 | 0.080 |
Why?
| | Enzyme Inhibitors | 2 | 2010 | 750 | 0.080 |
Why?
| | Blastocyst | 2 | 2001 | 44 | 0.080 |
Why?
| | Speech Perception | 2 | 2002 | 79 | 0.070 |
Why?
| | Amyloid beta-Peptides | 1 | 2010 | 189 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2022 | 5043 | 0.070 |
Why?
| | Psychological Tests | 1 | 2008 | 120 | 0.070 |
Why?
| | Age Factors | 5 | 2016 | 2894 | 0.070 |
Why?
| | Diagnosis, Differential | 4 | 2013 | 1342 | 0.070 |
Why?
| | Growth Inhibitors | 2 | 1997 | 43 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2009 | 222 | 0.070 |
Why?
| | Patch-Clamp Techniques | 4 | 2003 | 239 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2004 | 1226 | 0.070 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2022 | 94 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 872 | 0.070 |
Why?
| | Trans-Activators | 3 | 2000 | 367 | 0.070 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 1997 | 23 | 0.070 |
Why?
| | Conduct Disorder | 1 | 2009 | 193 | 0.070 |
Why?
| | RNA, Neoplasm | 2 | 1998 | 80 | 0.070 |
Why?
| | Kinetics | 7 | 1997 | 1551 | 0.070 |
Why?
| | Orbital Neoplasms | 1 | 2006 | 21 | 0.070 |
Why?
| | Middle Aged | 12 | 2019 | 26719 | 0.070 |
Why?
| | Child | 13 | 2019 | 18404 | 0.070 |
Why?
| | Chromosome Mapping | 2 | 1999 | 487 | 0.070 |
Why?
| | Endometrial Neoplasms | 2 | 1998 | 141 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2009 | 2565 | 0.070 |
Why?
| | Social Behavior | 1 | 2009 | 267 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2008 | 194 | 0.070 |
Why?
| | Pituitary Neoplasms | 3 | 2000 | 157 | 0.070 |
Why?
| | Luteinizing Hormone | 6 | 1997 | 169 | 0.070 |
Why?
| | Arachidonic Acid | 3 | 2003 | 116 | 0.070 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2006 | 53 | 0.070 |
Why?
| | Benzodiazepines | 2 | 1997 | 116 | 0.060 |
Why?
| | Epithelium | 3 | 1996 | 295 | 0.060 |
Why?
| | Aging | 1 | 1995 | 1618 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 3 | 1997 | 395 | 0.060 |
Why?
| | Blotting, Southern | 2 | 1995 | 68 | 0.060 |
Why?
| | Sex Factors | 1 | 2010 | 1715 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2084 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 2 | 2000 | 608 | 0.060 |
Why?
| | Alzheimer Disease | 1 | 2010 | 442 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 2 | 1995 | 34 | 0.060 |
Why?
| | Postoperative Complications | 2 | 2018 | 2128 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2537 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2009 | 1947 | 0.060 |
Why?
| | DNA Primers | 2 | 1995 | 510 | 0.060 |
Why?
| | Glycoproteins | 2 | 1996 | 304 | 0.060 |
Why?
| | Fixation, Ocular | 1 | 2004 | 18 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 923 | 0.060 |
Why?
| | Iodine Radioisotopes | 2 | 1994 | 125 | 0.060 |
Why?
| | Norepinephrine | 2 | 2011 | 201 | 0.060 |
Why?
| | Radioimmunoassay | 4 | 1994 | 162 | 0.060 |
Why?
| | Quinidine | 2 | 2003 | 6 | 0.060 |
Why?
| | Schizophrenia | 1 | 2008 | 414 | 0.060 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2006 | 196 | 0.060 |
Why?
| | Visual Fields | 2 | 2002 | 77 | 0.050 |
Why?
| | Inflammation | 1 | 1993 | 2477 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1998 | 800 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2018 | 9084 | 0.050 |
Why?
| | Concept Formation | 1 | 2002 | 25 | 0.050 |
Why?
| | Serotonin Receptor Agonists | 2 | 2000 | 27 | 0.050 |
Why?
| | Pituitary Hormone-Releasing Hormones | 2 | 1994 | 10 | 0.050 |
Why?
| | Discrimination Learning | 2 | 2008 | 47 | 0.050 |
Why?
| | Vocabulary | 1 | 2002 | 41 | 0.050 |
Why?
| | Biguanides | 2 | 2000 | 12 | 0.050 |
Why?
| | Blotting, Western | 2 | 1995 | 1147 | 0.050 |
Why?
| | Adolescent Behavior | 1 | 2007 | 489 | 0.050 |
Why?
| | Dopamine | 2 | 1996 | 236 | 0.050 |
Why?
| | Edema | 2 | 1993 | 119 | 0.050 |
Why?
| | Transcription, Genetic | 4 | 1997 | 1313 | 0.050 |
Why?
| | Rabbits | 3 | 1993 | 733 | 0.050 |
Why?
| | Natriuretic Peptides | 1 | 2022 | 8 | 0.050 |
Why?
| | Xenopus | 3 | 2001 | 97 | 0.050 |
Why?
| | Prevalence | 3 | 2019 | 2249 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 101 | 0.050 |
Why?
| | Signal Transduction | 5 | 2001 | 4509 | 0.050 |
Why?
| | Atrial Natriuretic Factor | 1 | 2022 | 55 | 0.050 |
Why?
| | Calcium Compounds | 1 | 2001 | 4 | 0.050 |
Why?
| | Neurons | 4 | 1997 | 1279 | 0.050 |
Why?
| | Spatial Behavior | 1 | 2001 | 20 | 0.050 |
Why?
| | Lactates | 1 | 2001 | 79 | 0.050 |
Why?
| | Microsurgery | 1 | 2022 | 59 | 0.050 |
Why?
| | Hypocalcemia | 1 | 2001 | 31 | 0.050 |
Why?
| | Sequence Alignment | 2 | 1999 | 323 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 113 | 0.050 |
Why?
| | Tritium | 2 | 2000 | 66 | 0.050 |
Why?
| | Predictive Value of Tests | 3 | 2011 | 1796 | 0.050 |
Why?
| | Cell Membrane | 2 | 1994 | 680 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 4689 | 0.040 |
Why?
| | Acute-Phase Proteins | 2 | 1997 | 64 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 1997 | 1314 | 0.040 |
Why?
| | Mesoderm | 1 | 2001 | 138 | 0.040 |
Why?
| | Infant | 5 | 2018 | 7959 | 0.040 |
Why?
| | Imagination | 1 | 2000 | 15 | 0.040 |
Why?
| | Radioligand Assay | 2 | 2000 | 43 | 0.040 |
Why?
| | DNA | 3 | 1995 | 1352 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2008 | 430 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2022 | 302 | 0.040 |
Why?
| | Phylogeny | 2 | 2003 | 789 | 0.040 |
Why?
| | Hormone Antagonists | 2 | 1997 | 33 | 0.040 |
Why?
| | Electrophysiology | 4 | 2003 | 201 | 0.040 |
Why?
| | Receptors, Eph Family | 1 | 1999 | 4 | 0.040 |
Why?
| | Tetraethylammonium | 1 | 1999 | 15 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 1999 | 20 | 0.040 |
Why?
| | Receptor, EphB4 | 1 | 1999 | 23 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 279 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2019 | 12542 | 0.040 |
Why?
| | Ovariectomy | 2 | 1996 | 116 | 0.040 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 2 | 1996 | 17 | 0.040 |
Why?
| | Immunoblotting | 2 | 1997 | 283 | 0.040 |
Why?
| | GTP-Binding Proteins | 2 | 1999 | 139 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2000 | 176 | 0.040 |
Why?
| | Postpartum Period | 2 | 1999 | 278 | 0.040 |
Why?
| | Cystadenocarcinoma, Papillary | 1 | 1999 | 5 | 0.040 |
Why?
| | Fallopian Tube Neoplasms | 1 | 1999 | 14 | 0.040 |
Why?
| | Uterine Contraction | 1 | 1999 | 17 | 0.040 |
Why?
| | Enoyl-CoA Hydratase | 1 | 1998 | 9 | 0.040 |
Why?
| | Adenoma | 1 | 2000 | 189 | 0.040 |
Why?
| | Serotonin | 1 | 2000 | 292 | 0.040 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 1998 | 22 | 0.040 |
Why?
| | Binding Sites | 3 | 1999 | 1168 | 0.040 |
Why?
| | Research | 1 | 2001 | 394 | 0.040 |
Why?
| | Actins | 1 | 2000 | 381 | 0.040 |
Why?
| | Fibroblast Growth Factor 9 | 1 | 1998 | 2 | 0.040 |
Why?
| | Spodoptera | 1 | 1998 | 36 | 0.040 |
Why?
| | Progestins | 1 | 1998 | 75 | 0.040 |
Why?
| | Baculoviridae | 1 | 1998 | 44 | 0.040 |
Why?
| | Photic Stimulation | 2 | 2018 | 203 | 0.040 |
Why?
| | Antibody Specificity | 2 | 1997 | 176 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 1998 | 43 | 0.040 |
Why?
| | Carcinoma, Embryonal | 1 | 1997 | 2 | 0.040 |
Why?
| | Species Specificity | 2 | 1996 | 542 | 0.040 |
Why?
| | Drainage | 1 | 2018 | 151 | 0.040 |
Why?
| | Medroxyprogesterone Acetate | 2 | 1998 | 28 | 0.040 |
Why?
| | Guinea Pigs | 1 | 1997 | 136 | 0.040 |
Why?
| | Peptones | 1 | 1997 | 1 | 0.040 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1999 | 226 | 0.040 |
Why?
| | Gastric Acid | 1 | 1997 | 13 | 0.040 |
Why?
| | Leiomyoma | 1 | 1997 | 44 | 0.040 |
Why?
| | Endothelin-1 | 1 | 1999 | 167 | 0.040 |
Why?
| | Lymphokines | 1 | 1997 | 111 | 0.040 |
Why?
| | Pulmonary Veins | 1 | 2018 | 81 | 0.040 |
Why?
| | Placental Lactogen | 1 | 1997 | 20 | 0.040 |
Why?
| | Oligopeptides | 2 | 1999 | 236 | 0.040 |
Why?
| | Neurosecretory Systems | 1 | 1997 | 32 | 0.030 |
Why?
| | Vaginal Neoplasms | 1 | 1996 | 11 | 0.030 |
Why?
| | Uterine Neoplasms | 1 | 1997 | 73 | 0.030 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1996 | 13 | 0.030 |
Why?
| | Tissue Polypeptide Antigen | 1 | 1996 | 2 | 0.030 |
Why?
| | Culture Media, Conditioned | 1 | 1997 | 105 | 0.030 |
Why?
| | Depression, Chemical | 1 | 1996 | 22 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1996 | 52 | 0.030 |
Why?
| | Phenylurea Compounds | 1 | 1997 | 82 | 0.030 |
Why?
| | Neoplasm Staging | 2 | 1998 | 1167 | 0.030 |
Why?
| | Oxytocin | 1 | 1996 | 45 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1996 | 43 | 0.030 |
Why?
| | Trophoblasts | 1 | 1998 | 163 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 502 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 1996 | 42 | 0.030 |
Why?
| | Carcinoma | 1 | 1998 | 198 | 0.030 |
Why?
| | Molecular Structure | 1 | 1997 | 434 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 255 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 1998 | 337 | 0.030 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 1996 | 22 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 935 | 0.030 |
Why?
| | Coenzyme A Ligases | 1 | 1995 | 11 | 0.030 |
Why?
| | Piperazines | 2 | 2000 | 309 | 0.030 |
Why?
| | Submandibular Gland | 1 | 1995 | 15 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 1997 | 385 | 0.030 |
Why?
| | Immune Sera | 1 | 1995 | 79 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2016 | 158 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 1996 | 157 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 1998 | 384 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 1995 | 48 | 0.030 |
Why?
| | Azepines | 2 | 2010 | 75 | 0.030 |
Why?
| | Receptors, Serotonin, 5-HT3 | 3 | 2000 | 15 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 473 | 0.030 |
Why?
| | Biological Transport | 1 | 1996 | 373 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1995 | 77 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 1995 | 54 | 0.030 |
Why?
| | Brain Chemistry | 1 | 1995 | 115 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1995 | 239 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 1995 | 46 | 0.030 |
Why?
| | Thyrotropin-Releasing Hormone | 3 | 1997 | 12 | 0.030 |
Why?
| | Muscle Contraction | 2 | 1996 | 389 | 0.030 |
Why?
| | Infertility, Male | 2 | 1985 | 59 | 0.030 |
Why?
| | Cystadenocarcinoma, Mucinous | 1 | 1994 | 14 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 292 | 0.030 |
Why?
| | Gestational Age | 1 | 1997 | 759 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 1996 | 178 | 0.030 |
Why?
| | Vibration | 2 | 1988 | 58 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 31 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 797 | 0.030 |
Why?
| | Inhibins | 1 | 1994 | 45 | 0.030 |
Why?
| | Receptor, Cholecystokinin B | 1 | 1994 | 1 | 0.030 |
Why?
| | Gastrins | 1 | 1994 | 8 | 0.030 |
Why?
| | Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 14 | 0.030 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 1994 | 44 | 0.030 |
Why?
| | Child, Preschool | 6 | 2011 | 9108 | 0.030 |
Why?
| | Haplorhini | 1 | 1994 | 57 | 0.030 |
Why?
| | Eye Infections, Viral | 1 | 1994 | 7 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 1996 | 448 | 0.030 |
Why?
| | HTLV-I Infections | 1 | 1994 | 21 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1644 | 0.030 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1994 | 34 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 1996 | 372 | 0.030 |
Why?
| | Posture | 2 | 1988 | 152 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 63 | 0.030 |
Why?
| | Pleurisy | 1 | 1993 | 6 | 0.030 |
Why?
| | Vestibular Nuclei | 1 | 1973 | 7 | 0.030 |
Why?
| | Hydrolysis | 1 | 1994 | 173 | 0.030 |
Why?
| | Ear, External | 1 | 1993 | 23 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1993 | 36 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 1997 | 821 | 0.030 |
Why?
| | Neuropeptides | 1 | 1993 | 65 | 0.030 |
Why?
| | Reference Values | 2 | 1997 | 742 | 0.030 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1993 | 72 | 0.030 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 1993 | 4 | 0.030 |
Why?
| | Cardiac Conduction System Disease | 1 | 2013 | 4 | 0.030 |
Why?
| | Mothers | 1 | 2019 | 651 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2018 | 712 | 0.030 |
Why?
| | Gestrinone | 1 | 1992 | 1 | 0.030 |
Why?
| | Mice, Nude | 1 | 1994 | 630 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 1994 | 213 | 0.030 |
Why?
| | Receptors, Cell Surface | 2 | 1985 | 355 | 0.030 |
Why?
| | Down-Regulation | 1 | 1995 | 594 | 0.030 |
Why?
| | Extracellular Space | 1 | 1993 | 116 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 1993 | 47 | 0.030 |
Why?
| | Cyclic AMP | 1 | 1993 | 227 | 0.030 |
Why?
| | Uveitis | 1 | 1994 | 115 | 0.030 |
Why?
| | Myocardium | 1 | 1998 | 913 | 0.030 |
Why?
| | Energy Intake | 1 | 1995 | 427 | 0.030 |
Why?
| | Therapy, Computer-Assisted | 1 | 2013 | 58 | 0.030 |
Why?
| | Androgen-Insensitivity Syndrome | 2 | 1985 | 5 | 0.030 |
Why?
| | Triglycerides | 1 | 1994 | 467 | 0.030 |
Why?
| | Phospholipids | 1 | 1994 | 197 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2014 | 293 | 0.030 |
Why?
| | Weight Gain | 1 | 1995 | 453 | 0.030 |
Why?
| | Isoflavones | 1 | 2012 | 16 | 0.020 |
Why?
| | Cell Division | 1 | 1993 | 758 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2013 | 160 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 908 | 0.020 |
Why?
| | Dihydrotestosterone | 2 | 1996 | 39 | 0.020 |
Why?
| | Social Control, Informal | 1 | 2011 | 18 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1994 | 444 | 0.020 |
Why?
| | Placebos | 1 | 2012 | 197 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2011 | 43 | 0.020 |
Why?
| | Central Venous Pressure | 1 | 2011 | 12 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1997 | 1700 | 0.020 |
Why?
| | Models, Genetic | 1 | 2014 | 562 | 0.020 |
Why?
| | Pain | 1 | 1997 | 705 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1993 | 253 | 0.020 |
Why?
| | Renin | 1 | 2011 | 31 | 0.020 |
Why?
| | Ovary | 1 | 1992 | 191 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 2011 | 46 | 0.020 |
Why?
| | Equipment Design | 1 | 2013 | 508 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 8628 | 0.020 |
Why?
| | Sheep | 1 | 1993 | 764 | 0.020 |
Why?
| | Testis | 3 | 1985 | 133 | 0.020 |
Why?
| | Flurbiprofen | 1 | 2010 | 3 | 0.020 |
Why?
| | Stroop Test | 1 | 2010 | 26 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2010 | 21 | 0.020 |
Why?
| | Hyperprolactinemia | 1 | 1990 | 4 | 0.020 |
Why?
| | Prolactinoma | 1 | 1990 | 11 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1430 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 493 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1996 | 795 | 0.020 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2010 | 54 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1691 | 0.020 |
Why?
| | Membrane Potentials | 3 | 2000 | 248 | 0.020 |
Why?
| | Dermatologic Agents | 2 | 2009 | 57 | 0.020 |
Why?
| | Alanine | 1 | 2010 | 104 | 0.020 |
Why?
| | Taurine | 1 | 2010 | 41 | 0.020 |
Why?
| | Ovarian Diseases | 1 | 1989 | 12 | 0.020 |
Why?
| | Hypothalamic Diseases | 1 | 1989 | 17 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2010 | 4411 | 0.020 |
Why?
| | Pituitary Diseases | 1 | 1989 | 22 | 0.020 |
Why?
| | Environment | 1 | 2011 | 332 | 0.020 |
Why?
| | Neural Pathways | 1 | 2011 | 261 | 0.020 |
Why?
| | Infertility, Female | 1 | 1990 | 94 | 0.020 |
Why?
| | Electric Conductivity | 2 | 2002 | 88 | 0.020 |
Why?
| | Protein Binding | 1 | 1994 | 1889 | 0.020 |
Why?
| | Color | 1 | 2009 | 74 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 125 | 0.020 |
Why?
| | Photography | 1 | 2009 | 88 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 811 | 0.020 |
Why?
| | Kidney | 1 | 1995 | 1188 | 0.020 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2009 | 56 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 161 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 944 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 588 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2012 | 460 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1075 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1989 | 221 | 0.020 |
Why?
| | Apoptosis | 1 | 1996 | 2362 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2007 | 58 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2008 | 86 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 1660 | 0.020 |
Why?
| | Estrogens, Conjugated (USP) | 2 | 1978 | 34 | 0.020 |
Why?
| | Neurons, Afferent | 1 | 1988 | 85 | 0.020 |
Why?
| | Janus Kinase 1 | 2 | 1997 | 23 | 0.020 |
Why?
| | Pilot Projects | 1 | 2012 | 1372 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 434 | 0.020 |
Why?
| | Foot | 1 | 1988 | 103 | 0.020 |
Why?
| | Bromocriptine | 2 | 1990 | 26 | 0.020 |
Why?
| | Protein Kinase C | 2 | 1999 | 273 | 0.020 |
Why?
| | Faculty | 1 | 2007 | 130 | 0.020 |
Why?
| | Cystectomy | 1 | 2006 | 32 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1999 | 785 | 0.020 |
Why?
| | Preoperative Care | 2 | 1999 | 319 | 0.020 |
Why?
| | Menotropins | 1 | 1985 | 2 | 0.020 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2006 | 57 | 0.020 |
Why?
| | Progesterone | 3 | 1996 | 232 | 0.020 |
Why?
| | Thalamic Nuclei | 2 | 1984 | 8 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 284 | 0.020 |
Why?
| | Alleles | 1 | 2008 | 789 | 0.020 |
Why?
| | Molecular Weight | 2 | 1996 | 331 | 0.020 |
Why?
| | Models, Biological | 2 | 2003 | 1620 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2008 | 458 | 0.020 |
Why?
| | Comorbidity | 1 | 2009 | 1448 | 0.010 |
Why?
| | Cats | 4 | 1984 | 193 | 0.010 |
Why?
| | Aged | 4 | 2006 | 19061 | 0.010 |
Why?
| | Phosphorylation | 2 | 1999 | 1569 | 0.010 |
Why?
| | Propafenone | 1 | 2003 | 2 | 0.010 |
Why?
| | Quinine | 1 | 2003 | 11 | 0.010 |
Why?
| | Barium | 1 | 2003 | 25 | 0.010 |
Why?
| | Ethanolamines | 1 | 2003 | 19 | 0.010 |
Why?
| | Glyburide | 1 | 2003 | 35 | 0.010 |
Why?
| | Lidocaine | 1 | 2003 | 40 | 0.010 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 69 | 0.010 |
Why?
| | Biopsy | 1 | 2006 | 1036 | 0.010 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2003 | 106 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 2 | 1999 | 785 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 3328 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2003 | 151 | 0.010 |
Why?
| | Delayed Rectifier Potassium Channels | 1 | 2002 | 9 | 0.010 |
Why?
| | Shab Potassium Channels | 1 | 2002 | 18 | 0.010 |
Why?
| | Risk Assessment | 1 | 2011 | 2967 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2003 | 511 | 0.010 |
Why?
| | Lung | 1 | 2014 | 3558 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 117 | 0.010 |
Why?
| | Fetal Proteins | 1 | 2001 | 16 | 0.010 |
Why?
| | Perciformes | 1 | 2001 | 17 | 0.010 |
Why?
| | Muscle Spindles | 1 | 1981 | 6 | 0.010 |
Why?
| | Clomiphene | 1 | 1981 | 15 | 0.010 |
Why?
| | Skin | 1 | 1985 | 655 | 0.010 |
Why?
| | Amenorrhea | 1 | 1981 | 27 | 0.010 |
Why?
| | Protein Subunits | 1 | 2002 | 201 | 0.010 |
Why?
| | Ovulation Induction | 1 | 1981 | 49 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 3408 | 0.010 |
Why?
| | Fibroblasts | 1 | 1985 | 837 | 0.010 |
Why?
| | Phalloidine | 1 | 2000 | 2 | 0.010 |
Why?
| | Cytochalasin B | 1 | 2000 | 17 | 0.010 |
Why?
| | T-Box Domain Proteins | 1 | 2001 | 92 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 1879 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 56 | 0.010 |
Why?
| | Kruppel-Like Factor 6 | 1 | 2000 | 1 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 796 | 0.010 |
Why?
| | Tubocurarine | 1 | 2000 | 4 | 0.010 |
Why?
| | Spinal Cord | 1 | 2003 | 347 | 0.010 |
Why?
| | Ondansetron | 1 | 2000 | 8 | 0.010 |
Why?
| | Ferrets | 1 | 2000 | 19 | 0.010 |
Why?
| | Serotonin Antagonists | 1 | 2000 | 30 | 0.010 |
Why?
| | Fatty Acids | 1 | 2003 | 381 | 0.010 |
Why?
| | Exocytosis | 1 | 2000 | 89 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2000 | 61 | 0.010 |
Why?
| | Cerebellar Nuclei | 1 | 1980 | 9 | 0.010 |
Why?
| | Actin Cytoskeleton | 1 | 2000 | 93 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2000 | 304 | 0.010 |
Why?
| | Ritodrine | 1 | 1999 | 1 | 0.010 |
Why?
| | Son of Sevenless Proteins | 1 | 1999 | 4 | 0.010 |
Why?
| | Imidazoles | 1 | 2000 | 208 | 0.010 |
Why?
| | Virulence Factors, Bordetella | 1 | 1999 | 19 | 0.010 |
Why?
| | Pertussis Toxin | 1 | 1999 | 26 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 6217 | 0.010 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1999 | 58 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1999 | 59 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 55 | 0.010 |
Why?
| | Cations | 1 | 1999 | 78 | 0.010 |
Why?
| | Zebrafish Proteins | 1 | 2001 | 246 | 0.010 |
Why?
| | Permeability | 1 | 1999 | 149 | 0.010 |
Why?
| | Postural Balance | 1 | 1981 | 183 | 0.010 |
Why?
| | Oocytes | 1 | 1999 | 170 | 0.010 |
Why?
| | Hemolytic Plaque Technique | 1 | 1997 | 29 | 0.010 |
Why?
| | Indoles | 1 | 2000 | 304 | 0.010 |
Why?
| | Secretory Rate | 1 | 1997 | 16 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1997 | 43 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4099 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1998 | 47 | 0.010 |
Why?
| | MAP Kinase Kinase 2 | 1 | 1997 | 27 | 0.010 |
Why?
| | Cervix Uteri | 1 | 1998 | 45 | 0.010 |
Why?
| | Endometrium | 1 | 1998 | 60 | 0.010 |
Why?
| | Leukemia Inhibitory Factor | 1 | 1997 | 6 | 0.010 |
Why?
| | Myometrium | 1 | 1998 | 35 | 0.010 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 1998 | 138 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1997 | 66 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 723 | 0.010 |
Why?
| | Pentagastrin | 1 | 1997 | 1 | 0.010 |
Why?
| | Devazepide | 1 | 1997 | 1 | 0.010 |
Why?
| | Famotidine | 1 | 1997 | 2 | 0.010 |
Why?
| | Atropine | 1 | 1997 | 25 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1997 | 14 | 0.010 |
Why?
| | Methacholine Chloride | 1 | 1997 | 47 | 0.010 |
Why?
| | Pituitary Gland, Posterior | 1 | 1997 | 2 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 2279 | 0.010 |
Why?
| | Genes, ras | 1 | 1997 | 91 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 1997 | 31 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 1997 | 64 | 0.010 |
Why?
| | Colchicine | 1 | 1997 | 24 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1997 | 25 | 0.010 |
Why?
| | Histamine | 1 | 1997 | 56 | 0.010 |
Why?
| | Injections, Intraventricular | 1 | 1997 | 71 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 147 | 0.010 |
Why?
| | Luciferases | 1 | 1997 | 142 | 0.010 |
Why?
| | Formaldehyde | 1 | 1997 | 46 | 0.010 |
Why?
| | Clusterin | 1 | 1996 | 10 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1997 | 68 | 0.010 |
Why?
| | Histamine H2 Antagonists | 1 | 1997 | 26 | 0.010 |
Why?
| | Tyrosine | 1 | 1997 | 214 | 0.010 |
Why?
| | Seizures | 1 | 1980 | 340 | 0.010 |
Why?
| | Stomach | 1 | 1997 | 102 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 1998 | 442 | 0.010 |
Why?
| | ROC Curve | 1 | 1998 | 442 | 0.010 |
Why?
| | Gene Deletion | 1 | 1998 | 356 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1996 | 91 | 0.010 |
Why?
| | G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1996 | 4 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 210 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1999 | 616 | 0.010 |
Why?
| | Dogs | 1 | 1997 | 334 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 1996 | 144 | 0.010 |
Why?
| | Chorionic Gonadotropin | 1 | 1976 | 78 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 1997 | 173 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 410 | 0.010 |
Why?
| | Conjugation, Genetic | 1 | 1975 | 5 | 0.010 |
Why?
| | Electric Stimulation | 2 | 1973 | 250 | 0.010 |
Why?
| | Mannose | 1 | 1975 | 21 | 0.010 |
Why?
| | Chlorides | 1 | 1996 | 127 | 0.010 |
Why?
| | Glucosamine | 1 | 1975 | 12 | 0.010 |
Why?
| | Receptors, FSH | 2 | 1985 | 9 | 0.010 |
Why?
| | Ciliophora | 1 | 1975 | 14 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 345 | 0.010 |
Why?
| | Dendrites | 1 | 1996 | 85 | 0.010 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1977 | 141 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1996 | 144 | 0.010 |
Why?
| | Activins | 1 | 1994 | 26 | 0.010 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 1994 | 26 | 0.010 |
Why?
| | Dexamethasone | 1 | 1996 | 317 | 0.010 |
Why?
| | Cross-Cultural Comparison | 1 | 1995 | 77 | 0.010 |
Why?
| | Eating | 1 | 1997 | 344 | 0.010 |
Why?
| | Axons | 1 | 1996 | 177 | 0.010 |
Why?
| | Adenosine | 1 | 1996 | 203 | 0.010 |
Why?
| | Semantics | 1 | 1995 | 89 | 0.010 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 1994 | 67 | 0.010 |
Why?
| | HTLV-I Antibodies | 1 | 1994 | 5 | 0.010 |
Why?
| | Estrogens | 1 | 1996 | 312 | 0.010 |
Why?
| | Natural Language Processing | 1 | 1995 | 72 | 0.010 |
Why?
| | Cytosol | 1 | 1994 | 208 | 0.010 |
Why?
| | Human T-lymphotropic virus 1 | 1 | 1994 | 23 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1143 | 0.010 |
Why?
| | Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1993 | 6 | 0.010 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 1993 | 15 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1131 | 0.010 |
Why?
| | Muscles | 2 | 1988 | 320 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 1994 | 138 | 0.010 |
Why?
| | Benztropine | 1 | 1993 | 2 | 0.010 |
Why?
| | Visual Cortex | 1 | 1973 | 41 | 0.010 |
Why?
| | Organ Specificity | 1 | 1994 | 268 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1993 | 36 | 0.010 |
Why?
| | Dopamine Antagonists | 1 | 1993 | 22 | 0.010 |
Why?
| | Gonadotropins, Equine | 1 | 1992 | 3 | 0.010 |
Why?
| | Aldehyde-Lyases | 1 | 1992 | 2 | 0.010 |
Why?
| | Hypophysectomy | 1 | 1992 | 15 | 0.010 |
Why?
| | Steroid 17-alpha-Hydroxylase | 1 | 1992 | 4 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 9 | 0.010 |
Why?
| | Electromyography | 2 | 1988 | 326 | 0.010 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 1992 | 4 | 0.010 |
Why?
| | Membrane Proteins | 1 | 1999 | 1018 | 0.010 |
Why?
| | Synapses | 1 | 1996 | 330 | 0.010 |
Why?
| | Aromatase | 1 | 1992 | 30 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1992 | 108 | 0.010 |
Why?
| | Oligodendroglia | 1 | 1994 | 148 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2218 | 0.010 |
Why?
| | Cortical Spreading Depression | 1 | 1971 | 13 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 448 | 0.010 |
Why?
| | Androgens | 1 | 1992 | 167 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 950 | 0.010 |
Why?
| | Neuroglia | 1 | 1971 | 150 | 0.010 |
Why?
| | Monitoring, Immunologic | 1 | 1989 | 23 | 0.010 |
Why?
| | Carcinoembryonic Antigen | 1 | 1989 | 37 | 0.010 |
Why?
| | Visual Pathways | 2 | 1984 | 44 | 0.010 |
Why?
| | Dermoid Cyst | 1 | 1989 | 12 | 0.010 |
Why?
| | Mutation | 1 | 1999 | 3344 | 0.000 |
Why?
| | Testosterone | 2 | 1984 | 343 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2311 | 0.000 |
Why?
| | RNA | 1 | 1993 | 809 | 0.000 |
Why?
| | Methoxyflurane | 1 | 1966 | 2 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1966 | 29 | 0.000 |
Why?
| | Gonadal Dysgenesis | 1 | 1985 | 8 | 0.000 |
Why?
| | Obesity | 1 | 1997 | 2507 | 0.000 |
Why?
| | Turner Syndrome | 1 | 1985 | 44 | 0.000 |
Why?
| | Hypothermia, Induced | 1 | 1966 | 66 | 0.000 |
Why?
| | Ischemia | 1 | 1988 | 362 | 0.000 |
Why?
| | Spermatogenesis | 1 | 1984 | 52 | 0.000 |
Why?
| | Evoked Potentials, Visual | 1 | 1984 | 30 | 0.000 |
Why?
| | Superior Colliculi | 1 | 1984 | 33 | 0.000 |
Why?
| | Half-Life | 1 | 1983 | 141 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1994 | 6344 | 0.000 |
Why?
| | Injections, Intravenous | 1 | 1983 | 198 | 0.000 |
Why?
| | Reflex, Stretch | 1 | 1981 | 9 | 0.000 |
Why?
| | Mechanoreceptors | 1 | 1981 | 12 | 0.000 |
Why?
| | Achilles Tendon | 1 | 1981 | 38 | 0.000 |
Why?
| | Brain Mapping | 1 | 1984 | 524 | 0.000 |
Why?
| | Nerve Block | 1 | 1981 | 60 | 0.000 |
Why?
| | Penicillin G | 1 | 1980 | 7 | 0.000 |
Why?
| | Cerebellar Cortex | 1 | 1980 | 21 | 0.000 |
Why?
| | Purkinje Cells | 1 | 1980 | 66 | 0.000 |
Why?
| | Leg | 1 | 1981 | 225 | 0.000 |
Why?
| | Drug Therapy, Combination | 1 | 1981 | 951 | 0.000 |
Why?
| | Antibiotics, Antitubercular | 1 | 1956 | 34 | 0.000 |
Why?
| | Neoplasms, Experimental | 1 | 1956 | 151 | 0.000 |
Why?
| | Geniculate Bodies | 1 | 1973 | 12 | 0.000 |
Why?
| | Potassium | 1 | 1971 | 128 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1956 | 1477 | 0.000 |
Why?
| | Chromatography, Gas | 1 | 1966 | 27 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1956 | 1879 | 0.000 |
Why?
| | Plethysmography | 1 | 1966 | 103 | 0.000 |
Why?
| | Brain Diseases | 1 | 1966 | 124 | 0.000 |
Why?
| | Cardiovascular Diseases | 1 | 1966 | 1727 | 0.000 |
Why?
|
|
Miyake's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|